DBV Technologies
id:
dbv-technologies-248-9516259
title:
DBV Technologies
text:
DBV Technologies SA is a publicly owned French biopharmaceutical firm headquartered in Bagneux, France. DBV Technologies is known for developing "Viaskin" technology for administering allergens or antigens to intact skin while avoiding any transfer to the blood. Viaskin Peanut clinical development has received Fast Track designation from the US Food and Drug Administration.
brand slug:
wiki
category slug:
encyclopedia
description:
original url:
https://en.wikipedia.org/wiki/DBV_Technologies
date created:
date modified:
2024-04-07T13:48:50Z
main entity:
{"identifier":"Q5204430","url":"https://www.wikidata.org/entity/Q5204430"}
image:
fields total:
13
integrity:
13